Key Financial Data Of Group

Modalis Therapeutics Corporation - Filing #7582738

Concept 2022-07-01 to
2022-09-30
As at
2022-09-30
2022-01-01 to
2022-09-30
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-09-30
2021-01-01 to
2021-09-30
2021-07-01 to
2021-09-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-1,314,537,000 JPY
-1,231,299,000 JPY
-661,924,000 JPY
Profit (loss) attributable to owners of parent
-1,309,827,000 JPY
-738,956,000 JPY
-181,372,000 JPY
Comprehensive income
-1,280,946,000 JPY
-731,801,000 JPY
-174,883,000 JPY
Net assets
4,283,934,000 JPY
5,549,212,000 JPY
6,093,605,000 JPY
Total assets
4,886,498,000 JPY
6,069,137,000 JPY
6,498,362,000 JPY
Basic earnings (loss) per share
-18.34
-45.04
-25.70
-6.32
-6.90
Diluted earnings per share
Equity-to-asset ratio
0.876 xbrli:pure
0.914 xbrli:pure
0.938 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.